{
    "nct_id": "NCT03703388",
    "official_title": "A Phase I Single-arm Dose Escalation Study to Determine the Safety and Bioavailability of a Natural Compound Arctigenin in Healthy Men",
    "inclusion_criteria": "1. Subjects consent to participate in the trial;\n2. The subject is 20-75 years of age;\n3. The subject is in healthy condition;\n4. The subject agrees to stop consuming or using arctigenin-containing products and supplement throughout the entire intervention period except for arctigenin capsules provided during study intervention.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 20 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "1. History of hepatitis or liver dysfunction;\n2. History of kidney disease or dysfunction;\n3. Ongoing alcohol abuse;\n4. Significant medical or psychiatric conditions that would make the patient a poor protocol candidate;\n5. Prior sensitivity or allergic reaction to arctigenin-containing products or supplements;\n6. Allergies to multiple food items or nutritional supplements;\n7. Taking antibiotics, anti-diabetic medicines, anti-cancer medicine, LHRH agonists, androgen receptor blocking agents, finasteride, or has undergone bilateral orchiectomy.",
    "miscellaneous_criteria": ""
}